Literature DB >> 16275845

CSF amyloid beta42 and tau levels correlate with AIDS dementia complex.

B J Brew1, L Pemberton, K Blennow, A Wallin, L Hagberg.   

Abstract

There is concern that AIDS dementia complex (ADC) may be complicated by Alzheimer disease (AD). Because AD presence and risk are related to CSF beta-amyloid(1-42) (Abeta42), total tau (t-tau), and phosphorylated tau (p-tau), the authors examined these in ADC, AD, and controls. ADC had significantly decreased CSF Abeta42 and increased t-tau and p-tau concentrations similar to AD, suggesting that ADC may be associated with AD or an AD-like process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275845     DOI: 10.1212/01.wnl.0000183293.95787.b7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  100 in total

Review 1.  Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.

Authors:  Benedetta Milanini; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2017-08       Impact factor: 5.071

2.  Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study.

Authors:  B M Ances; J J Christensen; M Teshome; J Taylor; C Xiong; P Aldea; A M Fagan; D M Holtzman; J C Morris; M A Mintun; D B Clifford
Journal:  Neurology       Date:  2010-06-09       Impact factor: 9.910

3.  Combined effects of aging and HIV infection on semantic verbal fluency: a view of the cortical hypothesis through the lens of clustering and switching.

Authors:  Jennifer E Iudicello; Steven Paul Woods; Reena Deutsch; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2012-01-31       Impact factor: 2.475

Review 4.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

5.  No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).

Authors:  Jan J Krut; Richard W Price; Henrik Zetterberg; Dietmar Fuchs; Lars Hagberg; Aylin Yilmaz; Paola Cinque; Staffan Nilsson; Magnus Gisslén
Journal:  Virulence       Date:  2016-07-19       Impact factor: 5.882

Review 6.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

7.  Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count.

Authors:  Radhika Adiga; Ahmet Y Ozdemir; Alexandra Carides; Melissa Wasilewski; William Yen; Pallavi Chitturi; Ronald Ellis; Dianne Langford
Journal:  J Neurovirol       Date:  2014-05-10       Impact factor: 2.643

Review 8.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

Review 9.  Role of HIV in amyloid metabolism.

Authors:  Mario Ortega; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-10       Impact factor: 4.147

10.  HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.

Authors:  Beau M Ances; David B Clifford
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.